To begin to test the hypothesis that plasma APOC3 plays a role in DKD, APOC3 levels were assessed in baseline plasma samples from the Veterans Affairs Diabetes Trial (VADT) (18, 19). This evidence concerns the gene APOC3 and diabetic kidney disease.